Advanced Enzyme Technologies logo

Advanced Enzyme Technologies MD, chairman, board of directors and AGM

NSE: ADVENZYMESBSE: 540025Pharmaceuticals & BiotechnologySmall Cap

Last close ₹248.35down ₹10.50 (4.06%)BSE ₹248.20

Share price at the NSE close on 23 Oct 2026. Previous close ₹258.85.

52-week range of traded prices to 23 Oct 2026
₹246.85Low, 23 Oct 2026₹419.00High, 11 May 2026
Market cap
₹2,760 Cr912th largest listed
P/E
16.6
P/B
1.7
Dividend yield
0.54%
ROE
10.9%
ROCE
10.8%
Debt to equity
0.01
Volume, NSE
3,27,06958.5% delivered

Advanced Enzyme Technologies board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonVasant L RathiRelated to the promoter
  • Company Secretary and Compliance OfficerSanjay Basantani

9 directors5 independent1 executive3 non-executive

  • Vasant L Rathi · ChairpersonNon-executive · joined Mar 1993 · 1 listed board · 1 committee seat
  • Pramod KasatIndependent · joined Dec 2016 · reappointed Dec 2021 · 117 months as independent · 5 listed boards · 4 as independent · 8 committee seats, 2 as chair
  • Mukund Madhusudan KabraExecutive · joined Sep 1999 · 1 listed board · 2 committee seats
  • Rasika RathiNon-executive · joined Jan 2019 · 1 listed board
  • Vinodkumar Hiralal JajooIndependent · joined Feb 2019 · reappointed Feb 2024 · 91 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
  • Sunny SharmaNon-executive · joined Nov 2019 · 2 listed boards · 1 committee seat
  • Nitin Jagannath DeshmukhIndependent · joined Jul 2022 · reappointed Jul 2022 · 51 months as independent · 1 listed board · 1 as independent · 4 committee seats
  • Vandana R TilakIndependent · joined Jul 2023 · reappointed Jul 2023 · 39 months as independent · 1 listed board · 1 as independent · 1 committee seat
  • Pradip Bhailal ShahIndependent · joined Jun 2026 · reappointed Jun 2026 · 3 months as independent · 1 listed board · 1 as independent

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left
  • Rajshree Patel, left 11 Jun 2026: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 8 Aug 20268 of 9 present4 independent · 90 days in between
    • 9 May 20268 of 9 present4 independent

  • Audit Committee

    Chair Vinodkumar Hiralal Jajoo

    Pramod Kasat, Vasant L Rathi, Vandana R Tilak

    • 8 Aug 20263 of 4 present2 independent · 90 days in between
    • 9 May 20263 of 4 present2 independent

  • Nomination and remuneration committee

    Chair Pramod Kasat

    Vasant L Rathi, Nitin Jagannath Deshmukh

    No meeting listed in the filing.

  • Stakeholders Relationship Committee

    Chair Vinodkumar Hiralal Jajoo

    Mukund Madhusudan Kabra, Nitin Jagannath Deshmukh

    No meeting listed in the filing.

  • Risk Management Committee

    Chair Vinodkumar Hiralal Jajoo

    Mukund Madhusudan Kabra, Rasika Rathi, Beni Prasad Rauka, Sanjay Basantani

    • 10 Jul 20263 of 3 present1 independent

  • Corporate Social Responsibility Committee

    Chair Mukund Madhusudan Kabra

    Vasant L Rathi, Vandana R Tilak

    No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • M S K A Associates & LLPPeer-review certificate valid to Jul 2027
1 earlier auditor
  • M S K A & AssociatesNamed in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Advanced Enzyme Technologies AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Advanced Enzyme Technologies dividend history

Annual general meeting, 31 Jul 2026

64,959 shareholders on the register on 24 Jul 2026; present: 2 promoters and 104 others; votes counted by Shiv Hari Jalan / Shiv Hari Jalan & Co..The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2026 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2026 together with the Auditors’ report thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 61.12% · promoters 99.04% · institutions 53.43% · other public 8.50%

  2. To declare final Dividend (Rs. 1.35/- per Equity Share) on the Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2026
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 61.15% · promoters 99.04% · institutions 53.51% · other public 8.50%

  3. To appoint a Director in place of Ms. Rasika Rathi (DIN: 08300682), who retires by rotation and being eligible, offers herself for re-appointment as a Director
    Ordinary
    99.96% for0.04% against

    Against: promoters 0.00% · institutions 0.12% · other public 0.13%

    Turnout: all 61.15% · promoters 99.04% · institutions 53.51% · other public 8.50%

  4. To reappoint M/s. MSKA & Associates LLP (Firm Registration No. 105047W/W101187) (Formerly known as MSKA & Associates) as the Statutory Auditors of the Company and fix their remuneration.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.11%

    Turnout: all 61.15% · promoters 99.04% · institutions 53.51% · other public 8.50%

  5. Re-appointment of Mr. Mukund Madhusudan Kabra (DIN: 00148294) as a Whole-time Director of the Company
    Ordinary
    99.80% for0.20% against

    Against: promoters 0.00% · institutions 0.73% · other public 0.13%

    Turnout: all 61.15% · promoters 99.04% · institutions 53.51% · other public 8.50%

  6. Appointment of Mr. Pradip Bhailal Shah (DIN: 01225582) as an Independent Director of the Company
    Special
    96.91% for3.09% against

    Against: promoters 0.00% · institutions 11.77% · other public 0.08%

    Turnout: all 61.15% · promoters 99.04% · institutions 53.51% · other public 8.50%

  7. Approval for payment of the remuneration of Ms. Manasi Kabra (Immediate Relative of Whole Time Director) who holds Office or Place of Profit in the Subsidiary of the Company in USA.
    Ordinary
    95.61% for4.39% against

    Against: promoters 0.00% · institutions 16.11% · other public 0.56%

    Turnout: all 58.90% · promoters 97.77% · institutions 53.51% · other public 2.15%

  8. Approval of Material Related Party Transactions with JC Biotech Private Limited, Subsidiary
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.37%

    Turnout: all 16.46% · promoters 0.00% · institutions 53.51% · other public 1.56%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Jul 2025, 5 resolutions

67,516 shareholders on the register on 23 Jul 2025; present: 2 promoters and 118 others; votes counted by Shiv Hari Jalan / Shiv Hari Jalan & Co..The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2025 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2025 together with the Auditors’ report thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 64.04% · promoters 99.83% · institutions 92.20% · other public 7.03%

  2. To declare final Dividend (Rs. 1.20/- per Equity Share) on the Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 64.06% · promoters 99.83% · institutions 92.33% · other public 7.03%

  3. To appoint a Director in place of Mr. Mukund Kabra (DIN: 00148294), who retires by rotation and being eligible, offers himself for re-appointment as a Director
    Ordinary
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 0.39% · other public 0.12%

    Turnout: all 64.06% · promoters 99.83% · institutions 92.33% · other public 7.03%

  4. Appointment of Mr. Shiv Hari Jalan, Proprietor of M/s. Shiv Hari Jalan & Co., Company Secretary in Practice (C.P. No. 4226) as the Secretarial Auditor for a period of five consecutive years and fix the RemunerationMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 64.06% · promoters 99.83% · institutions 92.33% · other public 7.03%

  5. Related Party Transactions with JC Biotech Private Limited, Subsidiary
    OrdinaryPromoters have an interest in it
    95.04% for4.96% against

    Against: promoters 0.00% · institutions 5.15% · other public 0.22%

    Turnout: all 19.20% · promoters 0.00% · institutions 92.33% · other public 2.01%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 25 Jul 2024, 5 resolutions

Present: 2 promoters and 96 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2024 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2024 together with the Auditors’ report thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 73.54% · promoters 100.00% · institutions 88.95% · other public 34.76%

  2. To declare final Dividend (Rs. 1.10/- per Equity Share) on the Equity Shares of Rs. 2/-neach, for the financial year ended March 31, 2024
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 73.57% · promoters 100.00% · institutions 89.13% · other public 34.76%

  3. To appoint a Director in place of Mr. Vasant Rathi (DIN: 01233447), who retires bynrotation and being eligible, offers himself for re-appointment as a Director
    Ordinary
    99.66% for0.34% against

    Against: promoters 0.00% · institutions 1.40% · other public 0.02%

    Turnout: all 73.57% · promoters 100.00% · institutions 89.13% · other public 34.76%

  4. Related Party Transactions with JC Biotech Private Limited, Subsidiary
    OrdinaryPromoters have an interest in it
    99.73% for0.27% against

    Against: promoters 0.00% · institutions 0.43% · other public 0.02%

    Turnout: all 28.84% · promoters 0.00% · institutions 89.13% · other public 30.14%

  5. Ratification of remuneration of M/s. Shilpa & Co. (Firm Registration Number:n100558), the Cost Auditors of the Company for the financial year ending March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 73.57% · promoters 100.00% · institutions 89.13% · other public 34.76%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 12 Aug 2023, 8 resolutions

Present: 1 promoter and 81 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2023 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2023 together with the Auditors’ report thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 64.12% · promoters 92.45% · institutions 63.43% · other public 9.95%

  2. To declare final Dividend (Rs. 1/- per Equity Share) on the Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2023
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 64.19% · promoters 92.45% · institutions 63.70% · other public 9.95%

  3. To appoint a Director in place of Dr. Sunny Sharma (DIN: 02267273), who retires by rotation and being eligible, offers himself for re-appointment as a Director.
    Ordinary
    99.36% for0.64% against

    Against: promoters 0.00% · institutions 2.19% · other public 0.07%

    Turnout: all 64.19% · promoters 92.45% · institutions 63.70% · other public 9.95%

  4. Related Party Transactions with JC Biotech Private Limited, Subsidiary
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.25%

    Turnout: all 19.49% · promoters 0.00% · institutions 63.70% · other public 2.85%

  5. Appointment of Ms. Vandana R. Tilak (DIN: 10048021) as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 64.19% · promoters 92.45% · institutions 63.70% · other public 9.95%

  6. Re-Appointment of Mr. Vinodkumar Hiralal Jajoo (DIN: 08224980) as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 64.19% · promoters 92.45% · institutions 63.70% · other public 9.95%

  7. Re-Appointment of Ms. Rajshree Patel (DIN: 08761022) as an Independent Director of the Company
    Special
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.10% · other public 0.17%

    Turnout: all 64.19% · promoters 92.45% · institutions 63.70% · other public 9.94%

  8. Approval for payment of Commission to the Non- Executive Directors for a term of five financial years commencing from April 01, 2024
    OrdinaryPromoters have an interest in it
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.24%

    Turnout: all 28.67% · promoters 16.10% · institutions 63.70% · other public 9.95%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 19 Aug 2022, 9 resolutions

Present: 3 promoters and 81 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2022 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2022 together with the Auditors’ report thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 69.44% · promoters 81.09% · institutions 97.60% · other public 10.30%

  2. To declare final Dividend (Re. 1/- per Equity Share) on the Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2022
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 69.50% · promoters 81.09% · institutions 97.85% · other public 10.30%

  3. To appoint a Director in place of Ms. Rasika Rathi (DIN: 08300682), who retires by rotation and being eligible, offers herself for re-appointment as a Director
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.14%

    Turnout: all 69.50% · promoters 81.09% · institutions 97.85% · other public 10.30%

  4. Continuation of Directorship of Mr. Vasant Rathi, Non-Executive Director (DIN: 01233447) in terms of Regulation 17(1A) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015MoreLess
    Special
    99.91% for0.09% against

    Against: promoters 0.00% · institutions 0.25% · other public 0.13%

    Turnout: all 69.50% · promoters 81.09% · institutions 97.85% · other public 10.30%

  5. Related Party Transactions with JC Biotech Private Limited, Subsidiary
    OrdinaryPromoters have an interest in it
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.90%

    Turnout: all 24.92% · promoters 0.00% · institutions 97.85% · other public 1.99%

  6. Appointment of Mr. Nitin Jagannath Deshmukh (DIN: 00060743) as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 69.50% · promoters 81.09% · institutions 97.85% · other public 10.30%

  7. Reclassification of the status from “Promoter Group” category to “Public” category
    OrdinaryPromoters have an interest in it
    91.79% for8.21% against

    Against: promoters 0.00% · institutions 21.70% · other public 0.57%

    Turnout: all 64.73% · promoters 75.40% · institutions 97.85% · other public 2.34%

  8. Approval of AETL - Employee Stock Option Scheme 2022
    Special
    91.36% for8.64% against

    Against: promoters 0.00% · institutions 24.51% · other public 0.32%

    Turnout: all 69.50% · promoters 81.09% · institutions 97.85% · other public 10.30%

  9. Grant of stock options to the employees of the Subsidiaries of the Company under AETL - Employee Stock Option Scheme 2022
    Special
    91.36% for8.64% against

    Against: promoters 0.00% · institutions 24.51% · other public 0.36%

    Turnout: all 69.50% · promoters 81.09% · institutions 97.85% · other public 10.30%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 8 Sep 2021, 11 resolutions

Present: 2 promoters and 85 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2021 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2021 together with the Auditors’ report thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 70.21% · promoters 80.29% · institutions 93.77% · other public 20.14%

  2. To declare Final Dividend (Rs. 0.90/- per Equity Share) on Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2021
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 70.26% · promoters 80.29% · institutions 93.98% · other public 20.14%

  3. To appoint a Director in place of Mr. Vasant Rathi (DIN: 01233447), who retires by rotation and being eligible, offers himself for re-appointment as a Director
    Ordinary
    99.90% for0.10% against

    Against: promoters 0.00% · institutions 0.27% · other public 0.06%

    Turnout: all 70.26% · promoters 80.29% · institutions 93.98% · other public 20.14%

  4. To appoint M/s. MSKA & Associates (Firm Registration No. 105047W) as the Statutory Auditors of the Company and fix their remuneration
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 70.13% · promoters 80.29% · institutions 93.98% · other public 19.57%

  5. Ratification of remuneration payable to M/s. Shilpa & Co. (Firm Registration Number: 100558), the Cost Auditors of the Company for the financial year ending March 31, 2022
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.04%

    Turnout: all 70.26% · promoters 80.29% · institutions 93.98% · other public 20.14%

  6. Re-appointment of Mr. Mukund Kabra (DIN: 00148294) as a Whole-Time Director of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.10%

    Turnout: all 68.63% · promoters 80.29% · institutions 93.98% · other public 12.87%

  7. Re-appointment of Mr. Pramod Kasat (DIN: 00819790) as an Independent Director of the Company
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.04% · other public 0.09%

    Turnout: all 70.26% · promoters 80.29% · institutions 93.98% · other public 20.14%

  8. Related Party Transactions with Advanced Bio-Agro Tech Limited, Subsidiary
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 26.18% · promoters 0.00% · institutions 93.98% · other public 10.80%

  9. Related Party Transactions with JC Biotech Private Limited, Subsidiary
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 26.18% · promoters 0.00% · institutions 93.98% · other public 10.81%

  10. Continuation of office of profit and remuneration terms of Mr. Kishor Rathi, Deputy General Manager (Promoter Group Member)
    OrdinaryPromoters have an interest in it
    94.08% for5.92% against

    Against: promoters 0.00% · institutions 6.49% · other public 0.14%

    Turnout: all 26.08% · promoters 0.00% · institutions 93.98% · other public 10.34%

  11. Reclassification of the status from “Promoter/Promoter Group” category to “Public” category
    OrdinaryPromoters have an interest in it
    12.96% for87.04% against

    Against: promoters 100.00% · institutions 62.46% · other public 95.93%

    Turnout: all 70.19% · promoters 80.29% · institutions 93.98% · other public 19.81%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 15 Jul 2020, 13 resolutions

Present: 5 promoters and 71 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2020 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2020 together with the Auditors’ report thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.95% · promoters 73.05% · institutions 94.15% · other public 31.96%

  2. To declare Final Dividend (Rs. 0.60/- per Equity Share) on Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2020
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.95% · promoters 73.05% · institutions 94.15% · other public 31.96%

  3. To appoint a Director in place of Mr. Mukund Kabra (DIN: 00148294), who retires by rotation and being eligible, offers himself for re-appointment as a Director
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.95% · promoters 73.05% · institutions 94.15% · other public 31.96%

  4. To approve Related Party Transactions with Advanced Bio-Agro Tech Limited, Subsidiary
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 23.45% · promoters 0.00% · institutions 94.15% · other public 22.66%

  5. To approve Related Party Transactions with JC Biotech Private Limited, Subsidiary
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 23.45% · promoters 0.00% · institutions 94.15% · other public 22.66%

  6. To ratify the remuneration payable to M/s. Shilpa & Co. (Firm Registration Number: 100558), the Cost Auditors of the Company for the financial year ending March 31, 2021
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.95% · promoters 73.05% · institutions 94.15% · other public 31.96%

  7. To consider and grant approval for Mr. Vasant Rathi (Promoter Chairman and Non-Executive Director) to continue to hold Office or Place of Profit in the Subsidiaries of the Company in USA and approval of remuneration payable theretoMoreLess
    OrdinaryPromoters have an interest in it
    93.23% for6.77% against

    Against: promoters 0.00% · institutions 8.64% · other public 0.00%

    Turnout: all 23.45% · promoters 0.00% · institutions 94.15% · other public 22.66%

  8. To consider and grant approval for Mrs. Prabhavati Rathi (Promoter Group Member) to continue to hold Office or Place of Profit in the Subsidiaries of the Company in USA and approval of remuneration payable thereto.MoreLess
    OrdinaryPromoters have an interest in it
    93.23% for6.77% against

    Against: promoters 0.00% · institutions 8.64% · other public 0.01%

    Turnout: all 23.45% · promoters 0.00% · institutions 94.15% · other public 22.66%

  9. To consider and grant approval for Ms. Rachana Rathi (Promoter Group Member) to continue to hold an Office or Place of Profit in the Subsidiaries of the Company in USA and approval of remuneration payable thereto.MoreLess
    OrdinaryPromoters have an interest in it
    93.23% for6.77% against

    Against: promoters 0.00% · institutions 8.64% · other public 0.01%

    Turnout: all 23.45% · promoters 0.00% · institutions 94.15% · other public 22.66%

  10. To consider and grant approval for Ms. Rasika Rathi (Non-Executive Director and Promoter Group Member) to continue to hold an Office or Place of Profit in the Subsidiaries of the Company in USA and approval of remuneration payable thereto.MoreLess
    OrdinaryPromoters have an interest in it
    93.23% for6.77% against

    Against: promoters 0.00% · institutions 8.64% · other public 0.01%

    Turnout: all 23.45% · promoters 0.00% · institutions 94.15% · other public 22.66%

  11. To consider and grant approval for Ms. Reshma Rathi (Promoter Group Member) to continue to hold an Office or Place of Profit in the Subsidiaries of the Company in USA and approval of remuneration payable thereto.MoreLess
    OrdinaryPromoters have an interest in it
    93.23% for6.77% against

    Against: promoters 0.00% · institutions 8.64% · other public 0.01%

    Turnout: all 23.45% · promoters 0.00% · institutions 94.15% · other public 22.66%

  12. To approve appointment of Dr. Sunny Sharma (DIN: 02267273) as a Non-Executive Director of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.95% · promoters 73.05% · institutions 94.15% · other public 31.96%

  13. To approve appointment of Mrs. Rajshree Patel (DIN: 08761022) as an Independent Director of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.95% · promoters 73.05% · institutions 94.15% · other public 31.96%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 8 Aug 2019, 12 resolutions

Present: 2 promoters and 108 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt:n(a) the Audited Financial Statements (Standalone) of the Company for the Financial Year ended March 31, 2019 together with the Auditors’ report thereon and the report of the Board of Directors of the Company.n(b) the Audited Financial Statements (Consolidated) of the Company for the Financial Year ended March 31, 2019 together with the Auditors’ report thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.21% · promoters 73.68% · institutions 95.56% · other public 27.92%

  2. To declare final Dividend (Rs. 0.60/- per Equity Share) on Equity Shares of Rs. 2/- each, for the Financial Year ended March 31, 2019
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.21% · promoters 73.68% · institutions 95.56% · other public 27.92%

  3. To re-appoint Mrs. Savita Rathi (DIN: 00365717), who retires by rotation and being eligible, offers herself for reappointment as a Director
    OrdinaryPromoters have an interest in it
    22.70% for77.30% against

    Against: promoters 83.18% · institutions 53.61% · other public 98.75%

    Turnout: all 75.70% · promoters 88.57% · institutions 95.56% · other public 27.74%

  4. To consider & expressly resolve not to fill-up the vacancy in case the re-appointment of the Director as per above Item No. 3 of the AGM Notice is not approved
    Ordinary
    88.73% for11.27% against

    Against: promoters 16.82% · institutions 0.00% · other public 0.02%

    Turnout: all 75.74% · promoters 88.57% · institutions 95.56% · other public 27.92%

  5. To approve Related Party Transactions with Advanced Bio-Agro Tech Limited
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 23.07% · promoters 0.00% · institutions 94.63% · other public 20.48%

  6. To approve Related Party Transactions with JC Biotech Private Limited
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 23.07% · promoters 0.00% · institutions 94.63% · other public 20.48%

  7. To approve remuneration payable to Mrs. Mangala Kabra, General Manager (Related Party)
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 31.03% · promoters 13.66% · institutions 95.56% · other public 20.30%

  8. To approve the payment of Commission to the Non-Executive Directors for a term of five financial years commencing from April 01, 2019
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 32.22% · promoters 12.62% · institutions 95.56% · other public 27.92%

  9. To approve re-appointment of Mr. Kedar Desai (DIN: 00322581) as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 67.21% · promoters 73.68% · institutions 95.56% · other public 27.92%

  10. To approve appointment of Ms. Rasika Rathi (DIN: 08300682) as a Non-Executive Director of the Company
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 67.16% · promoters 73.68% · institutions 95.56% · other public 27.74%

  11. To approve appointment of Mr. Vilas Murlidhar Aurangabadkar (DIN: 08225986) as an Independent Director of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.16% · promoters 73.68% · institutions 95.56% · other public 27.74%

  12. To approve appointment of Mr. Vinodkumar Hiralal Jajoo (DIN: 08224980) as an Independent Director of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 67.16% · promoters 73.68% · institutions 95.56% · other public 27.74%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 31 Jul 2026, 3 fund houses so far (houses' deadline to file 15 Oct 2026)

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2026 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2026 together with the Auditors’ report thereon.MoreLess
    3 for0 against
  • To declare final Dividend (Rs. 1.35/- per Equity Share) on the Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2026
    3 for0 against
  • To appoint a Director in place of Ms. Rasika Rathi (DIN: 08300682), who retires by rotation and being eligible, offers herself for re-appointment as a Director
    3 for0 against
  • To reappoint M/s. MSKA & Associates LLP (Firm Registration No. 105047W/W101187) (Formerly known as MSKA & Associates) as the Statutory Auditors of the Company and fix their remuneration.
    3 for0 against
  • Re-appointment of Mr. Mukund Madhusudan Kabra (DIN: 00148294) as a Whole-time Director of the Company
    Against Angel One Mutual Fund
    • Angel One Mutual FundGovernance concern: Considering the spirit and intent of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, ESOPs should not form part of the remuneration package as the director is related to member of Promoter Group; No absolute cap on variable pay or total remuneration.
    2 for1 against
  • Appointment of Mr. Pradip Bhailal Shah (DIN: 01225582) as an Independent Director of the Company
    Against Angel One Mutual Fund, ICICI Prudential Mutual Fund, Jio BlackRock Mutual Fund
    • Angel One Mutual FundGovernance concern: The director holds excessive shareholding in the Company; raises concerns regarding potential conflicts of interest.
    • ICICI Prudential Mutual FundPradip Shah, 72, is the Cofounder and Chief Executive Officer of Washington Garment Dyeing & Finishing, Inc. The AMC took note that from 1993 till 2016, he served as a Non-Executive Non - Independent Director on the board of the company and as disclosed in the notice, serves on the board of Advanced Enzymes, USA – a wholly owned subsidiary of the company. However, the company has not provided information of his tenure as a director of Advanced Enzymes, USA. Therefore, the AMC is unable to ascertain if a complete dissociation has taken place. Further, his shareholding in the company is at 1.66% - as on 31 March 2026 is material, raising concerns over his board independence. Given the lack of clarity and undisclosed information the AMC has voted against the resolution.
    • Jio BlackRock Mutual FundPradip Shah, 72, is the Cofounder and Chief Executive Officer of Washington Garment Dyeing & Finishing, Inc. He is an entrepreneur, operator, and investor with four decades of experience in building and leading businesses in the United States. We note that from 1993 till 2016, he served as a Non-Executive Non - Independent Director on the board of the company and as disclosed in the notice, serves on the board of Advanced Enzymes, USA – a wholly owned subsidiary of the company. The company has not provided information of his tenure as a director of Advanced Enzymes, USA. Therefore, we are unable to ascertain if a complete dissociation has taken place. Furthermore, we note that his shareholding in the company at 1.66% - as on 31 March 2026 is material, raising concerns over his board independence. We do not support the resolution.Amendments in SEBI’s LODR require directors having attained the age of 75 to be approved by shareholders through a special resolution. We do not consider age to be a criterion for board memberships.
    0 for3 against
  • Approval for payment of the remuneration of Ms. Manasi Kabra (Immediate Relative of Whole Time Director) who holds Office or Place of Profit in the Subsidiary of the Company in USA.
    Against Angel One Mutual Fund, ICICI Prudential Mutual Fund
    • Angel One Mutual FundGovernance and Transparency Concern: Inadequate disclosure regarding the proposed appointee’s profile and the remuneration determination process, which limits shareholders' ability to independently assess the appropriateness of the proposed remuneration package, hence fairness of proposed remuneration cannot be ascertained.
    • ICICI Prudential Mutual FundMs. Manasi Kabra, is the daughter Mukund M Kabra - Whole-Time Director, was appointed as Corporate Strategy Analyst of Cal – India Foods International d/b/a Specialty Enzymes and Probiotics, step-down wholly owned subsidiary of the Company in USA on 02 February 2026. Her proposed remuneration structure is hourly based and estimated at Rs 3.7 mn annually. The contract terms are open-ended, permitting annual increases of up to 15% with no clarity on her role, responsibilities, performance metrics or for using a per-hour compensation model—a structure typically reserved for external consultants rather than individuals fully involved in corporate operations. Furthermore, the resolution allows her to hold this office of profit in perpetuity. Given the lack of clarity, the AMC had voted against the resolution.
    0 for2 against
  • Approval of Material Related Party Transactions with JC Biotech Private Limited, Subsidiary
    3 for0 against
1 proposal not matched to one resolution
  • Approve continuation of Ms. Manasi Kabra (Corporate Strategy Analyst) in an office of profit and payment of her remuneration from 01 October 2026
    Against Jio BlackRock Mutual Fund
    • Jio BlackRock Mutual FundMs. Manasi Kabra, is the daughter Mukund M Kabra - Whole-Time Director. She was appointed Corporate Strategy Analyst of Cal – India Foods International d/b/a Specialty Enzymes and Probiotics, step-down wholly owned subsidiary of the Company in USA on 02 February 2026. Her proposed remuneration structure is hourly based and estimated at Rs 3.7 mn annually. The contract terms are open-ended, permitting annual increases of up to 15% with no clarity on her role, responsibilities, or performance metrics. We also note that there is no clarity provided for using a per-hour compensation model—a structure typically reserved for external consultants rather than individuals fully involved in corporate operations. Shareholders need to engage with the company to understand the rationale behind her remuneration structure and also clarify if this framework applies to other employees. Furthermore, the resolution allows her to hold this office of profit in perpetuity. We believe her reappointment must be periodically approved by shareholders. We do not support the resolution.
    0 for1 against

Mutual fund votes, meeting of 30 Jul 2025, 10 fund houses

  • To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2025 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2025 together with the Auditors’ report thereonMoreLess
    10 for0 against
  • To declare final Dividend (Rs. 1.20/- per Equity Share) on the Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2025
    10 for0 against
  • To appoint a Director in place of Mr. Mukund Kabra (DIN: 00148294), who retires by rotation and being eligible, offers himself for re-appointment as a Director
    10 for0 against
  • Appointment of Mr. Shiv Hari Jalan, Proprietor of M/s. Shiv Hari Jalan & Co., Company Secretary in Practice (C.P. No. 4226) as the Secretarial Auditor for a period of five consecutive years and fix the RemunerationMoreLess
    10 for0 against
  • Related Party Transactions with JC Biotech Private Limited, Subsidiary
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Bank of India Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Angel One Mutual FundGovernance Concern: Basis of arm’s length pricing not disclosed.
    • Bandhan Mutual Fund, Bank of India Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Basis of arm’s length pricing not disclosed.
    5 for5 against
6 earlier meetings

Mutual fund votes, meeting of 25 Jul 2024, 5 fund houses

  • To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2024 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2024 together with the Auditors’ report thereon.MoreLess
    5 for0 against
  • To declare final Dividend (Rs. 1.10/- per Equity Share) on the Equity Shares of Rs. 2/-neach, for the financial year ended March 31, 2024
    5 for0 against
  • To appoint a Director in place of Mr. Vasant Rathi (DIN: 01233447), who retires bynrotation and being eligible, offers himself for re-appointment as a Director
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with the law. No concern on the merit of appointee. Re-appointment is non-compliant with law. Director appointment beyond 75 years of age proposed through ordinary resolution as against Special Resolution required under SEBI LODR Regulations. Governance Concern: Non-Executive Chairman is related to Executive Director of the Company.
    3 for2 against
  • Related Party Transactions with JC Biotech Private Limited, Subsidiary
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with Law. Governance Concern: Basis for Arm’s Length pricing not disclosed.
    3 for2 against
  • Ratification of remuneration of M/s. Shilpa & Co. (Firm Registration Number:n100558), the Cost Auditors of the Company for the financial year ending March 31, 2025
    5 for0 against

Mutual fund votes, meeting of 12 Aug 2023, 3 fund houses

  • To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2023 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2023 together with the Auditors’ report thereon.MoreLess
    3 for0 against
  • To declare final Dividend (Rs. 1/- per Equity Share) on the Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2023
    3 for0 against
  • To appoint a Director in place of Dr. Sunny Sharma (DIN: 02267273), who retires by rotation and being eligible, offers himself for re-appointment as a Director.
    3 for0 against
  • Related Party Transactions with JC Biotech Private Limited, Subsidiary
    3 for0 against
  • Appointment of Ms. Vandana R. Tilak (DIN: 10048021) as an Independent Director of the Company
    3 for0 against
  • Re-Appointment of Mr. Vinodkumar Hiralal Jajoo (DIN: 08224980) as an Independent Director of the Company
    3 for0 against
  • Re-Appointment of Ms. Rajshree Patel (DIN: 08761022) as an Independent Director of the Company
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundNo concern on the merit of proposed appointee. Non-Compliance: Re-appointment is not in accordance with law, no prior shareholders’ approval obtained for re-appointment as an ID.
    2 for1 against
  • Approval for payment of Commission to the Non- Executive Directors for a term of five financial years commencing from April 01, 2024
    3 for0 against

Mutual fund votes, meeting of 19 Aug 2022, 5 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2022 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2022 together with the Auditors’ report thereonMoreLess
    5 for0 against
  • To declare final Dividend (Re. 1/- per Equity Share) on the Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2022
    5 for0 against
  • To appoint a Director in place of Ms. Rasika Rathi (DIN: 08300682), who retires by rotation and being eligible, offers herself for re-appointment as a Director
    5 for0 against
  • Continuation of Directorship of Mr. Vasant Rathi, Non-Executive Director (DIN: 01233447) in terms of Regulation 17(1A) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015MoreLess
    5 for0 against
  • Related Party Transactions with JC Biotech Private Limited, Subsidiary
    5 for0 against
  • Appointment of Mr. Nitin Jagannath Deshmukh (DIN: 00060743) as an Independent Director of the Company
    5 for0 against
  • Reclassification of the status from “Promoter Group” category to “Public” category
    Against HDFC Mutual Fund, ITI Mutual Fund, Nippon India Mutual Fund
    • HDFC Mutual FundAs one of the promoters seeking reclassification is the father of a Whole time director, it is not appropriate to classify the same as public category
    • ITI Mutual FundNon-Compliant as per Regulation 31A of the SEBI LODR.
    • Nippon India Mutual FundPartial re-classification of promoter group
    2 for3 against
  • Approval of AETL - Employee Stock Option Scheme 2022
    Against HDFC Mutual Fund, ITI Mutual Fund, Nippon India Mutual Fund
    • HDFC Mutual FundESOPs are being granted at a significant discount to market price
    • ITI Mutual FundExercise price inadequately disclosed.
    • Nippon India Mutual FundInadequate disclosure
    1 for3 against
  • Grant of stock options to the employees of the Subsidiaries of the Company under AETL - Employee Stock Option Scheme 2022
    Against HDFC Mutual Fund, ITI Mutual Fund, Nippon India Mutual Fund
    • HDFC Mutual FundESOPs are being granted at a significant discount to market price
    • ITI Mutual FundExercise price inadequately disclosed.
    • Nippon India Mutual FundInadequate disclosure
    2 for3 against
1 proposal not matched to one resolution
  • To authorize Board of Directors to create, grant, offer and issue, in one or more tranches, not exceeding 25,00,000 (Twenty Five Lakhs) Options to such permanent employees of the Company whether working in or outside India and Directors of the Company whether Whole-Time Directors or not, including a NonExecutive Director who is not a Promoter or member of the Promoter group but excluding the Independent Directors, except: (a) a Promoter or a person who belongs to Promoter group (b) Director who, either himself/ herself or through his/her Relative or through any body corporate, directly or indirectly, holds more than 10% of the outstanding Equity Shares of the Company, under a scheme titled AETL Employee Stock Option Scheme 2022, not exceeding 25,00,000 (Twenty Five Lakhs) Equity SharesMoreLess
    1 for0 against

Mutual fund votes, meeting of 8 Sep 2021, 4 fund houses

  • To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2021 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2021 together with the Auditors’ report thereon.MoreLess
    4 for0 against
  • To declare Final Dividend (Rs. 0.90/- per Equity Share) on Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2021
    4 for0 against
  • To appoint a Director in place of Mr. Vasant Rathi (DIN: 01233447), who retires by rotation and being eligible, offers himself for re-appointment as a Director
    4 for0 against
  • To appoint M/s. MSKA & Associates (Firm Registration No. 105047W) as the Statutory Auditors of the Company and fix their remuneration
    4 for0 against
  • Ratification of remuneration payable to M/s. Shilpa & Co. (Firm Registration Number: 100558), the Cost Auditors of the Company for the financial year ending March 31, 2022
    4 for0 against
  • Re-appointment of Mr. Mukund Kabra (DIN: 00148294) as a Whole-Time Director of the Company
    4 for0 against
  • Re-appointment of Mr. Pramod Kasat (DIN: 00819790) as an Independent Director of the Company
    4 for0 against
  • Related Party Transactions with Advanced Bio-Agro Tech Limited, Subsidiary
    4 for0 against
  • Related Party Transactions with JC Biotech Private Limited, Subsidiary
    4 for0 against
  • Continuation of office of profit and remuneration terms of Mr. Kishor Rathi, Deputy General Manager (Promoter Group Member)
    4 for0 against
  • Reclassification of the status from “Promoter/Promoter Group” category to “Public” category
    Against HDFC Mutual Fund
    • HDFC Mutual FundAs the promoter, requesting the reclassification to public category, along with his relatives hold more than 10% of the equity of the company, it is not appropriate to classify the same as public category
    3 for1 against

Mutual fund votes, meeting of 15 Jul 2020, 5 fund houses

  • To receive, consider and adopt the Audited Financial Statements (Standalone) of the Company for the financial year ended March 31, 2020 together with the Auditors’ report thereon and the report of the Board of Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the financial year ended March 31, 2020 together with the Auditors’ report thereon.MoreLess
    3 for0 against

    2 abstained

  • To declare Final Dividend (Rs. 0.60/- per Equity Share) on Equity Shares of Rs. 2/- each, for the financial year ended March 31, 2020
    3 for0 against

    2 abstained

  • To appoint a Director in place of Mr. Mukund Kabra (DIN: 00148294), who retires by rotation and being eligible, offers himself for re-appointment as a Director
    3 for0 against

    2 abstained

  • To approve Related Party Transactions with Advanced Bio-Agro Tech Limited, Subsidiary
    3 for0 against

    2 abstained

  • To approve Related Party Transactions with JC Biotech Private Limited, Subsidiary
    3 for0 against

    2 abstained

  • To ratify the remuneration payable to M/s. Shilpa & Co. (Firm Registration Number: 100558), the Cost Auditors of the Company for the financial year ending March 31, 2021
    3 for0 against

    2 abstained

  • To consider and grant approval for Mr. Vasant Rathi (Promoter Chairman and Non-Executive Director) to continue to hold Office or Place of Profit in the Subsidiaries of the Company in USA and approval of remuneration payable theretoMoreLess
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundProposed resolution will allow to hold the office of profit in perpetuity. However, reappointment must be periodically approved by shareholders
    2 for1 against

    2 abstained

  • To consider and grant approval for Mrs. Prabhavati Rathi (Promoter Group Member) to continue to hold Office or Place of Profit in the Subsidiaries of the Company in USA and approval of remuneration payable thereto.MoreLess
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundProposed resolution will allow to hold the office of profit in perpetuity. However, reappointment must be periodically approved by shareholders
    2 for1 against

    2 abstained

  • To consider and grant approval for Ms. Rachana Rathi (Promoter Group Member) to continue to hold an Office or Place of Profit in the Subsidiaries of the Company in USA and approval of remuneration payable thereto.MoreLess
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundProposed resolution will allow to hold the office of profit in perpetuity. However, reappointment must be periodically approved by shareholders
    2 for1 against

    2 abstained

  • To consider and grant approval for Ms. Rasika Rathi (Non-Executive Director and Promoter Group Member) to continue to hold an Office or Place of Profit in the Subsidiaries of the Company in USA and approval of remuneration payable thereto.MoreLess
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundProposed resolution will allow to hold the office of profit in perpetuity. However, reappointment must be periodically approved by shareholders
    2 for1 against

    2 abstained

  • To consider and grant approval for Ms. Reshma Rathi (Promoter Group Member) to continue to hold an Office or Place of Profit in the Subsidiaries of the Company in USA and approval of remuneration payable thereto.MoreLess
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundProposed resolution will allow to hold the office of profit in perpetuity. However, reappointment must be periodically approved by shareholders
    2 for1 against

    2 abstained

  • To approve appointment of Dr. Sunny Sharma (DIN: 02267273) as a Non-Executive Director of the Company
    3 for0 against

    2 abstained

  • To approve appointment of Mrs. Rajshree Patel (DIN: 08761022) as an Independent Director of the Company
    3 for0 against

    2 abstained

Mutual fund votes, meeting of 8 Aug 2019, 3 fund houses

  • To receive, consider and adopt:n(a) the Audited Financial Statements (Standalone) of the Company for the Financial Year ended March 31, 2019 together with the Auditors’ report thereon and the report of the Board of Directors of the Company.n(b) the Audited Financial Statements (Consolidated) of the Company for the Financial Year ended March 31, 2019 together with the Auditors’ report thereon.MoreLess
    2 for0 against

    1 abstained

  • To declare final Dividend (Rs. 0.60/- per Equity Share) on Equity Shares of Rs. 2/- each, for the Financial Year ended March 31, 2019
    2 for0 against

    1 abstained

  • To re-appoint Mrs. Savita Rathi (DIN: 00365717), who retires by rotation and being eligible, offers herself for reappointment as a Director
    2 for0 against

    1 abstained

  • To consider & expressly resolve not to fill-up the vacancy in case the re-appointment of the Director as per above Item No. 3 of the AGM Notice is not approved
    2 for0 against

    1 abstained

  • To approve Related Party Transactions with Advanced Bio-Agro Tech Limited
    2 for0 against

    1 abstained

  • To approve Related Party Transactions with JC Biotech Private Limited
    2 for0 against

    1 abstained

  • To approve remuneration payable to Mrs. Mangala Kabra, General Manager (Related Party)
    2 for0 against

    1 abstained

  • To approve the payment of Commission to the Non-Executive Directors for a term of five financial years commencing from April 01, 2019
    2 for0 against

    1 abstained

  • To approve re-appointment of Mr. Kedar Desai (DIN: 00322581) as an Independent Director of the Company
    2 for0 against

    1 abstained

  • To approve appointment of Ms. Rasika Rathi (DIN: 08300682) as a Non-Executive Director of the Company
    2 for0 against

    1 abstained

  • To approve appointment of Mr. Vilas Murlidhar Aurangabadkar (DIN: 08225986) as an Independent Director of the Company
    2 for0 against

    1 abstained

  • To approve appointment of Mr. Vinodkumar Hiralal Jajoo (DIN: 08224980) as an Independent Director of the Company
    2 for0 against

    1 abstained

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Sep 2025.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.